Domestic Security Using Production Partnerships and Lessons from Yesterday Act of 2025 or the Domestic SUPPLY Act of 2025This bill establishes a program and sets out other requirements to promote domestic manufacturing of personal protective equipment (PPE) to address infectious diseases and other public health emergencies.Specifically, the Department of Health and Human Services (HHS) must establish a program to enter into purchasing agreements with eligible domestic manufacturers for PPE to prepare for and respond to public health emergencies. To be eligible, manufacturers must be majority owned and operated by U.S. citizens and must manufacture a majority of their contracted products domestically, with 100% of products manufactured domestically by 2028. HHS must coordinate with the Department of Defense and the Department of Homeland Security on this program.In addition, the federal government must only procure, subject to limited exceptions, clothing or equipment that is produced domestically to prevent the transmission of an infectious disease. If using federal funds, states or localities must also procure such items domestically.Further, the bill requires HHS to submit to Congress a report about changes to federal requirements for PPE since the beginning of the COVID-19 pandemic and the impact of those changes on health care workers who cared for patients in 2020 and 2021.
If enacted, HB 675 will have significant implications for federal procurement practices concerning PPE. The bill mandates that federal and state agencies may only use funds to purchase PPE manufactured in the United States, effectively prohibiting the acquisition of foreign-produced equipment, with limited exceptions. This shift aims to bolster local economies and support domestic manufacturing while ensuring that supplies meet strict quality and safety standards set forth by relevant health authorities. The legislation also requires manufacturers to gradually increase their domestic production to 100% by 2028, reinforcing a long-term commitment to self-sufficiency in PPE manufacturing.
House Bill 675, known as the Domestic Security Using Production Partnerships and Lessons from Yesterday Act of 2025 (Domestic SUPPLY Act), seeks to enhance the availability of personal protective equipment (PPE) in preparation for future public health emergencies. The bill directs the Secretary of Health and Human Services, in collaboration with other federal agencies, to establish partnerships with domestic manufacturers to ensure that qualified PPE is readily available. The initiative is motivated by the lessons learned from the COVID-19 pandemic, highlighting the need for robust domestic production capabilities in times of health crises.
The introduction of HB 675 has sparked debate regarding its potential effects on domestic manufacturing and public health preparedness. Proponents argue that by securing a steady supply of domestically produced PPE, the United States can better respond to future health emergencies, reduce dependency on foreign suppliers, and enhance national security. Conversely, opponents raise concerns about the feasibility and economic implications of such mandates, suggesting that the transition could result in increased costs for taxpayers and suppliers, as well as potential disruptions in supply chains during the adjustment period.